Home › Pharmaceuticals

Pharmaceuticals Market Research Reports & Consulting

The global pharmaceuticals market is experiencing constant growth due to the worldwide increase in life expectancy, as well as the increasing incidence of chronic and infectious diseases. The steadily increasing demand for innovative drugs has thus triggered a significant rise in R&D investments in the pharmaceuticals industry. Leading industry players allocate around 20% of their turnover to R&D to maintain a competitive edge. The emergence of biopharmaceuticals has opened a new arena for drug discovery; and breakthroughs in the fields of proteomics and genomics have also enabled drug manufacturers to develop more effective drugs and therapies. While the industry has begun attracting significant public funding and tax exemption, it still faces the challenges of short product lifecycles and of developing blockbuster drugs. The pharmaceuticals industry is dominated by the U.S., which holds around 45% of the global market share. However, the markets in emerging economies like in China and India are expected to show a double digit growth. This is because global pharmaceutical giants are increasingly outsourcing R&D to lower costs and to take advantage of the scientific work pool in these nations.

Market Reports

Title	Published	Price
In-Vitro Diagnostic (IVD) Market (Applications, End-users & Types) Trends & Global Forecasts (Major & Emerging Markets – G7, Japan & BRIC) (2011 - 2016) The Asian region is expected to be ruled by the emerging economies such as China and India, show the highest CAGR by the year 2016. The Chinese IVD market is taking frog leap amongst the emerging nations, followed by India, Russia, and Brazil. The major driving factor for the IVD industry to boom in the emerging countries is the government funding and improved healthcare facilities.	January 2012	$ 4650
Clinical Trial Management Systems (CTMS) Market: Global Trends, Opportunities, Challenge and Forecasts (2011 - 2016) A clinical trial deals with the application of specific clinical or scientific methods or medicine to human body. Clinical trials are used to identify the effect of particular treatment or medication on patients suffering from a particular disease. The process of a clinical trial starts with identification of the medication or the medical device to be tested. Participants for the trial are selected and the results are studied in order to define the effectiveness of the drug or device.	January 2012	$ 4650
Healthcare BPO Market - Payer (Claims processing), Provider (Medical Billing & Coding) and Pharmaceutical (Clinical trial & Contract manufacturing) Outsourcing - Global analysis & Forecasts (2011-2016) Outsourcing is the buzzword in the healthcare industry in the U.S., the rising cost of healthcare, less availability of man power, and quality worked provided by the vendors, are some of the factors driving the outsourcing of healthcare. There are three main segments of healthcare outsourcing covered in the report i.e.; payer, provider, and pharmaceutical. The payer (healthcare insurance companies), provider (hospitals) and the pharmaceutical companies are looking at outsourcing as a viable option to be competitive in the business. Healthcare reforms introduced by Obama government are also driving the healthcare outsourcing market.	January 2012	$ 5650
Acute Myeloid Leukemia Therapeutics Market in G8 Countries (2010 - 2020) Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age. Incidence rate of acute myeloid leukemia is high in men and women over 50 years. The acute myeloid leukemia market is segmented into two types; namely childhood acute myeloid leukemia and adulthood acute myeloid leukemia. The market was dominated by AVD regimen in 2010. However, in 2020, the market is expected to be dominated by AVD regimen, Cyatarabine, and Quizartinib drug.	December 2011	$ 4650
Chronic Lymphocytic Leukemia Therapeutics Market in G8 Countries (2010 - 2020) Chronic lymphocytic leukemia is the second most common cancer in adult males and rarely occurs in children. The risk of chronic lymphocytic leukemia is closely associated with age. About 90% of chronic lymphocytic leukemia is diagnosed in middle age. Incidence rate of CLL is high in men and women over 50 years of age. The chronic lymphocytic leukemia market is segmented into two types; namely childhood chronic lymphocytic leukemia and adulthood lymphocytic leukemia. The market was dominated by Campath drug in 2010. However, in 2020, the market is expected to be equally dominated by GA101/RG7159 molecule and Arzerra drug.	December 2011	$ 4650
Acute Lymphocytic Leukemia Therapeutics Market (Pipeline Forecast & Market Forecast in G8 Countries) (2010 - 2020) The incidence of acute lymphocytic leukemia is high in children from 0 to 14 years than the people aged above 14. It is the most common childhood acute lymphocytic leukemia. However, the acute lymphocytic leukemia may also occur in adults. Acute lymphocytic leukemia distribution depends on age. For instance, 30% of is diagnosed before the age of 5 and 55% of ALL age 15.The acute lymphocytic leukemia market is segmented into two types; namely childhood acute lymphocytic leukemia, and adult acute lymphocytic leukemia. The market was dominated by Hyper-CVAD regimen in 2010. However, in 2020, the market is expected to be equally dominated by Hyper-CVAD and Linker regimen.	December 2011	$ 4650
Active Pharmaceutical Ingredient (API) Market Trends, Competitive Landscape and Global Forecasts (2011-2016) The Development in the High Potency Active Pharmaceutical Ingredient (HPAPI) and Biogeneric drugs is boosting the growth of the Active Pharmaceutical Ingredient (API) market. There has been a paradigm shift in the use of innovative drugs to that of low-cost API drugs after the economic recession, thereby causing a positive impact on the overall growth of the API market. In order to keep abreast with this change, API manufacturers are applying various novel technologies to reduce the processing time in order to yield more production.	December 2011	$ 5650
Leukemia Therapeutics Market (2010-2020) (Acute/Chronic Lymphocytic Leukemia & Acute/Chronic Myeloid Leukemia) Pipeline Forecast & Market Forecast in G8 Countries Leukemia is the type of blood cancer and the ninth most common one in males. It accounts for almost 0.0148% of all the men and 0.009% of all the women worldwide. The leukemia market is segmented into four types; namely acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. The market was dominated by chronic myeloid leukemia in 2010. However, in 2020, the market is expected to be equally dominated by acute lymphocytic leukemia and chronic myeloid leukemia.	November 2011	$ 6500
Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast) Prostate cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost.	November 2011	$ 4650
Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries Lung cancer is responsible for most of the deaths (due to cancer) across the globe. With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer; having failed both chemotherapy and treatments with epidermal growth factor receptor (EFGR) - Tyrosine kinase inhibitor (TKI). Lung cancer is still an area with high unmet need for early diagnosis and limited treatment options in the advanced stages of lung cancer.	November 2011	$ 4650
Global Clinical Trials Market (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework) This research report categorizes the Global Clinical Trials Market on the basis of phases, indications, and study design analyzing trends in each. Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 20 company profiles.	September 2011	$ 4650
Global Nuclear Medicine (Medical Isotopes/ Radioisotopes/ Radiopharmaceuticals) Market in PET/SPECT Imaging and Therapy - Competitive Landscape, Current trends and Forecasts (2010 – 2015) Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems such as cardiac, cancer, neurology, and/or treat certain conditions such as cancers. The use of radiopharmaceuticals as tracer dates back to 1930’s. Over the years, technical advancement in production, diagnostic equipments (SPECT and PET), and discovery of new radiopharmaceutical have driven the market. The global radiopharmaceutical market for therapy and PET & SPECT imaging was valued at $3,213 million in 2010 and is expected to reach $4,734 million by 2015; growing at a CAGR of 8.1% from 2010 to 2015. The PET & SPECT diagnosis accounted for the largest share -90%- of the global radiopharmaceutical market.	August 2011	$ 4650
Global Lung Cancer Surgery Market (Devices & Treatment Outlook) – Trends & Challenges (2010 – 2015) The lung cancer surgery market is expected to grow at a CAGR of 4.9% during the study period (2010-2015). Thoracotomy is the most widely used surgical procedure for lung cancer treatment accounting for about 74% of all surgical interventions.	June 2011	$ 4650
U.S. Electronic Medical Records (EMR) Market, 2010-2015 (Market Share, Winning Strategies and Adoption Trends) EMR is a part of healthcare information technology that is used to make paperless computerized patient data in order to increase efficiency of hospital systems and reduce chances of errors in medical records. A substantial growth rate (More than 16%) of the U.S. healthcare IT spending and the government initiatives towards development of a nationwide healthcare information network is expected to push EMR implementation across the healthcare sector in the U.S. The rising demand for the healthcare cost containment and need to improve the quality of healthcare service are driving the growth of the EMR market in the U.S. The U.S. EMR market is expected to grow from $2,177 million in 2009 to $6,054 million in 2015 at an estimated CAGR of 18.1% during the forecast period 2010-2015.	June 2011	$ 4650
Healthcare IT Market in Emerging Economies (2010 – 2015) Countries such as Brazil, India, China and Russia are moving ahead to adopt such modern technologies to minimize healthcare cost and to provide primary and secondary healthcare services to large rural population. Technology driven healthcare programs such as Telemedicine projects are growing in all four countries. Such projects are increasing use of healthcare information technology. Since these countries are still in emerging stage in terms of HCIT usage hence it is essential to start with basic healthcare IT solutions such as EMR’s and CPOE. These technologies in their basic form can be easily implemented at minimal cost, at least in urban healthcare institutions. Government initiatives towards healthcare system development and modernization are the major reasons behind HCIT growth in these countries.	April 2011	$ 4650
Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) (2010 – 2015) This market research report analyzes the diabetes care devices market in Brazil, Russia, India, and China (BRIC) over the period 2010-2015. The report categorizes the overall market for diabetes care devices into the submarkets for insulin pumps, self-monitoring blood glucose systems, and continuous glucose monitoring systems.	April 2011	$ 4650
Worldwide Dermatology Devices Market (2010-2015) The dermatology devices studied and segmented in this report are as per their usage in the diagnosis and treatment of skin related disorders such as skin cancer (melanoma and non-melanoma), psoriasis, acne, scars, and others. The diagnostic devices analyzed are dermatoscopes, microscopes, imaging techniques such as MRI, CT and Optical Coherence Tomography (OCT) scanners. The total market for diagnostic devices was estimated to be $175 million in 2010, and is expected to grow at a CAGR of 7.3% from 2010 to 2015.	March 2011	$ 4650
Global Weight Loss & Diet Management Products & Services Market (2010 - 2015) Obesity and weight gain issues have always been major concerns impacting the health and fitness of the individuals. Increasing levels of awareness amongst the calorie conscious consumers have opened up new avenues and opportunities in this market.	February 2011	$ 4650
Global Anesthesia and Respiratory Devices Market (2010-2015) The global anesthesia and respiratory devices market is expected to witness moderate growth in the coming five years. Respiratory devices account for the largest share (about 57%) in this market; primarily due to their wide usage among the three consumer segments (healthcare institutions, home healthcare and transport) as compared to anesthesia devices; which have limited usage amongst the end-users.	February 2011	$ 4650
Strategic Analysis & Forecast of US Biopharmaceutical Industry (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.	February 2011	$ 4650
Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets (Pharmaceuticals, Medical devices and Health insurance) The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders.	August 2010	$ 4650
Pharma & Healthcare Social Media Marketing Strategies Increasing number of web users’ world wide (1.8 billion), development and popularity of web based community sites (Twitter, Facebook), tools and information centers (branded & unbranded sponsored communities) are changing approach towards Pharma and healthcare marketing and information sharing. In pharma industry social media has emerged as an effective tool for marketing, consumer engagement, monitoring & analyzing user generated content and building & changing brand perception. Social media is emerging as a strategic shift in organizations communication and operation model. Top pharmaceutical market players have started integrating social media in to their marketing mix. The effective social media marketing strategies that can help generate business exposure, market research data, relationship building and thus can prove as an important initiative to boom sales and overall business in the long term	August 2010	$ 4650
Global Cancer Biomarkers Market (2010 - 2015) Cancer is recognized as a major cause of mortality world over; accounting for 7.4 million (or 13%) of all deaths in 2004. The WHO estimates the incidence of cancer to continue rising to reach an estimated 9.2 million deaths in 2015. The rising prevalence of the disease forms one of the major factors driving the growth of the oncology biomarkers market.	June 2010	$ 4650
US Neonatal (Preterm) Infant Care Market (2010-2015) Preterm infant care forms a significant part of the pediatric healthcare market in U.S as preterm births are on a alarming rise in the nation. Preterm births are one of the leading causes of infant mortality in U.S with 1 in 8 births being preterm. Induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, smoking are some of the major reasons responsible for increasing incidence of preterm births in the country. Preterm infant care products such as infant care devices, infant formula and drugs face a great demand in United States due to the absolute necessity of such products in sustaining baby lives. The products are indispensable in saving preterm babies because they are biologically immature and require external medical assistance in the form of respiratory, nutritional and thermal control support for survival. Infant care products have helped to increase the survival of preterm babies in the country. The criticality of the products in preterm infant care is driving the market. Furthermore, technology advances in regards to multi function equipments are also propelling the growth of the market.	June 2010	$ 4650
Global Ophthalmology Drugs & Devices Market Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.	May 2010	$ 4650
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.	April 2010	$ 4650
Opportunity Analysis of H1N1 (swine flu) Vaccination Market The increase in public awareness and government initiatives, as a consequence of scare from pandemic flu has resulted in the drastic rise in demand for the Influenza Vaccines. This transient boost in demand of seasonal influenza vaccines is an impact of prevailing H1N1 pandemic, due to apprehension and lack of clarity among the general public. The emerging technologies in production are going to give a new face to the market dynamics of this market. The upcoming vaccines and drugs by various players in the market such as Novartis’ Optaflu and ProteinSciences’ FluBlock, along with the emerging technologies in production are going to give a new face to the market dynamics of this market.	November 2009	$ 4650
Autoimmune Treatment Market (2009 - 2014) The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market.	September 2009	$ 4650
Global Weight Loss and Diet Management Market (2009 - 2014) Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition.	July 2009	$ 4650
Diabetes Market (Devices and Drugs) Sedentary lifestyle has led to the increase in diabetic patients and increasing awareness of side effects caused if left undiagnosed has increased the number of patients turning out for diagnosis and regular check. Additionally diabetes devices has also been a leading market in home healthcare segment as well, with introduction of handy glucose monitors. The market is evidencing continued innovation addressing issues pertaining to painless and user friendly diagnostic devices, drugs with less side effects, Insulin delivery systems etc. The market dynamics in this industry compels the competitors to be aware of the competitive moves to enhance market revenues and retain market share	March 2012	$ 4650
Sales Force Effectiveness (2009 - 2014) Pharmaceutical companies are aiming to increase their return on investment (ROI) from their sales representatives. Improvement in rep performance reduces ineffective sales calls, optimizes cost per detail and increases revenue per call. Companies are thus exploring all available options under their sales force effectiveness strategy.	March 2012	$ 4650
Global Multiple Myeloma Drugs Market 2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. There has been a significant development in technologies and drugs/vaccines with respect to breast cancer, thyroid cancer, and pancreatic cancer therefore increasing the survival rates.	March 2012	$ 4650
Global Breast Cancer Drugs Market There are about one million new cases of breast cancer every year. Breast cancer accounts for about 10% of world wide cancer. There has been significant increase in awareness levels with respect to impact on survival rates incase of early diagnosis. Therefore, opening novel opportunities for breast cancer drugs market.	March 2012	$ 4650
World Wound Care Market (2010-2015) United States accounts for the largest share in the world wound care market, however developed markets such as Japan, and Europe are expected to register higher growth rates, especially in the advanced wound care segment. Growth has been attributed to the continued increase in challenging and chronic wounds due to lifestyle diseases such as diabetes and obesity. Rapidly aging population and hospital acquired infections are other factors driving the market for wound care.	March 2012	$ 4650
Global Colorectal Cancer Market (2010-2015) 2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate.	March 2012	$ 4650
Anti Nicotine Therapies (2010 - 2015) Smoking cessation products are gaining popularity in both OTC and prescription products market segments. Increasing burden on healthcare system due to deteriorating quality of life because of smoking and several side effects associated with the current smoking cessation marketed products, builds up the need of novel products with better efficacy in this market.	March 2012	$ 4650
Global Weight Loss Drugs, Supplements And Cosmetics Market Individuals with high BMI have a greater risk of developing diseases such as cancer and diabetes. This holds true for both men and women; and those with BMI above 35 are at the highest risk. However, increasing awareness about obesity is encouraging consumers to seek medical assistance and consultation for weight reduction. The market for weight-loss drugs, cosmetics, and supplements is witnessing a significant growth as these do not involve strict diet or exercise regimens. Top pharmaceutical companies have thus increased R&D investments for anti-obesity drugs with minimal or no side effects.	March 2012	$ 4650
Monoclonal Antibodies Market (2010 - 2015) The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008. Monoclonal antibodies present significant opportunities as they are targeted therapy (They impact only the diseased cells and do not harm healthy cells) unlike chemotherapy drugs.	March 2012	$ 4650
Clinical Information systems (CIS) Market (2011-2016) Clinical information systems include software solutions that enable efficient clinical workflow. Clinical systems include EMR, computerized physician order entry, laboratory information systems, pharmacy information systems, radiology information systems, and PACS. The clinical information systems market in developed countries is growing with higher CAGR, however emerging markets are currently very nascent. Presently, clinical information systems dominate the HIS market due to their high price and rising adoption. Budgetary constraints due to low awareness levels are however restraining market growth. The global clinical information systems market is expected to grow from $1.2 billion in 2009 to $2.8 billion in 2015, at an estimated CAGR of 14.8% from 2010 to 2015.	March 2012	$ 4650
Reforming Healthcare Payer Market Through Latest Technology Models There has been an increase in the advent of novel and innovative solutions in the healthcare payer market. These solutions offer better technology models supporting healthcare payers in providing with better investments while reducing the risks and financial constraints. The healthcare payers are seeking for the customized solutions which facilitate multiple applications and offer a distinctive technology environment.	March 2012	$ 4650
Global Oncology Pharmaceuticals & Therapeutics Market Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles.	March 2012	$ 4650
Global Human Immunodeficiency Virus (HIV) Market (2010 – 2015) Human immunodeficiency virus (HIV) is a retrovirus which causes Acquired Immunodeficiency syndrome (AIDS) in humans, a condition where immune system fails, leading to opportunistic infections that is life threatening. HIV infection occurs via transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk and major routes of infection transmission are unsafe sex, contaminated needles, perinatal transmission, breast milk and infected blood products.	March 2012	$ 4650
Non Clinical Information Systems Market (2011-2016) Non-clinical healthcare systems (NCHS) facilitate revenue cycle management and also offer automatic patient billing, cost accounting, payroll, and claims management. These functions gain high significance in light of the reported fact that improper revenue cycle management in hospitals causes a 3% to 5% loss of net revenue. For a 250-bed hospital, this figure means an annual loss of $3.5 million to $7.5 million. Improved r e lat ion with payors and patients are improved revenue cycle management are driving this market. The administrative/non-clinical systems market revenue was $12.5 billion globally in 2010. The Non Clinical Information Systems Market is estimated to reach $20.9 billion in 2015 growing at a CAGR of 10.8%.	March 2012	$ 4650
Global Pediatric Healthcare Market (2010 - 2015) Children often suffer from short term diseases related to respiratory or ocular infections. Apart from these, gastrointestinal infections accompanied by diarrhea and injury related disorders are common in children. Many times these are just short term diseases and treated on daily basis by pediatricians but treatment of these diseases consume large amount of time and financial resources of their parents and caregivers involved in primary care. Change in lifestyle has been a major factor for increased prevalence of such diseases.	March 2012	$ 4650
Global Market For Cloud Computing In Healthcare Healthcare is one of the most highly complex and fragmented verticals out of the lot supporting a widespread and diversified professional user population (i.e., clinicians) along with patients’ in life-critical situations. The healthcare industry is currently facing growing economic and regulatory pressures that make its IT infrastructure ripe for a radical change. In the light of these two factors the organizations in the healthcare industry need to take a closer look at the potential benefits of cloud computing.	March 2012	$ 4650
US Practice Management Systems Market (Ambulatory practice/Physician practice) (2011-2016) Physicians use practice management systems for administrative purposes and revenue cycle management. These systems improve organizational workflow, productivity, and the organization’s financial performance. The market also offers EMR-integrated physicians practice management systems. However, standalone applications are more popular because of the high cost of these integrated systems. The global physician practice management systems market is expected to be worth $4.2 billion by 2014, growing at a CAGR of 8.2% from 2009 to 2014.	March 2012	$ 4650
Electronic Medical Records (EMR) Market in Emerging Countries - Outlook (2011-2016) The development of EMR and EHR from standalone to highly integrated IT communication systems is expected to provide new opportunities in the healthcare IT applications market. Further market growth depends on factors such as improvements in data integration, information security, and post-sale services. Integrated systems are widely used for applications such as telemedicine, home telemetry, and remote patient monitoring. These applications also form a huge revenue generating business for the HCIT market; and hold great potential in regions with a dearth of other medical resources.	March 2012	$ 4650
Global Pharmaceutical Packaging Devices Market (2011-2016) The trend of pharmaceutical packaging is changing towards manufacturing safer and cost effecive drugs. The U.S. FDA is promoting the presence of RFID tag on the primary packaging to enhance safety of the product. The EU is encouraging medical packaging with Braille information for sight-impaired customers. Quality packaging not only increases safety but also enhances the aesthetic value of the product. These factors are responsible for driving the pharmaceutical packaging devices market.	April 2012	$ 4650
Clinical Laboratory Services Market - Growth Opportunities, Competitive Analysis and Competitor Profiles (2011-2016) Clinical laboratories are an essential part of the healthcare industry. It is estimated that approximately 80% of a physician's diagnoses are a result of laboratory tests. The constant pressure to reduce healthcare spending is shifting healthcare utilization in favor of the laboratory, making it an even more valuable part of the treatment plan. As hospital stays are shortened, contact between the physician and patient is reduced, which places a larger role on labs to gather, interpret, and deliver accurate information to the physician in a timely manner.	April 2012	$ 4650
Clinical Research Management Systems (CRMS) Market: Trends, Opportunities, Challenges & Global Forecasts (2011-2016) Clinical Research Management System (CRMS) is a computer-based software system used to manage large amount of data related to clinical research planning, preparation, performance, and reporting. CRMS deals with the management of pharmacovigilance tasks, clinical trial management (CTMS), and regulatory filings management. It also helps to simplify the regulatory assessment and reporting process, thereby shortening the time taken to develop and market a new drug. CRMS is offered into three different delivery modes such as on-demand CRMS, (Saas) web-based CRMS, and cloud computing-based CRMS. Clinical Research Management System (CRMS) market is divided into three categories based on end-users such as provider CRMS market, pharmaceutical CRMS market, and Clinical Research Organizations (CRO) CRMS market.	April 2012	$ 4650
Erectile Dysfunction, Premature Ejaculation & Alopecia Market - Global Forecasts (2011-2016) The development of erectile dysfunction is associated with an underlying cause which is organic in nature. Drug induced causes of erectile dysfunction are common and can complicate the medical management of underlying conditions such as hypertension, depression, and BPH. Beta blockers, selective serotonin reuptake inhibitors (SSRIs), and the uroselective alpha adrenergic receptor antagonists have been associated with the loss of libido or ejaculatory disorders, which can result in drug discontinuation by patients and suboptimal treatment of these conditions.	April 2012	$ 4650
Global Nanomedical Devices and Therapeutics Market (2011-2016) Nanomedicine, an application of nanotechnology in medical science, is an evolving market. It represents an important segment of nanotechnology which will significantly change the course of treating life threatening diseases. This, unlike other treatment options, is significantly expected to enhance efficacy and minimize overall adversities. Toxicity and environmental impact of nanoscale materials are the major problems nanomedicine. Research and development in nanomedicine is expected to offer a pool of novel products which will improve the health of patients. The robust product pipeline for nanobiomaterials poses a health picture of the market creates significant growth opportunities. However these will have to go through stringent testing protocols before commercialization.	April 2012	$ 4650
Wireless Healthcare Market - Technologies, Applications, Trends and Global Forecasts (2011-2016) Wireless technologies hold immense potential to take healthcare delivery and services to the next level by bringing healthcare to the patients’ homes. Excellent quality medical treatment - similar to what is given in the hospitals - is expected to reach the patients’ doorsteps due to availability of long range and high speed wireless technologies. Need for better quality healthcare delivery and shift from clinical care to home care is currently driving the wireless technologies market in the healthcare sector. Further, need to cut down on healthcare expenditure is a prime driving force for the growth of this wireless healthcare market.	April 2012	$ 4650